|Articles|September 21, 2011
Podcast: The Case for Upgrading existing HPLC Assays to UPLC
Advertisement
Eric Hill of Impact Analytical discusses the emergence new analytical technologies, specifically UPLC. He outlines the advantages of converting existing HPLC assays to UPLC, including both increased performance and cost savings. With minimal upfront investment, the long term gains are significant.
Add this Podcast feed to your media player
WHITEPAPERS
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Writing the Biological Script: Scaling DNA Manufacturing for the Next Generation of Therapeutics
2
FDA Approves Pfizer’s Breast Cancer Treatment
3
Thermo Fisher's Kane Says AI Is Reshaping How CDMOs Add Value
4
Pharma Fundamentals: Hold Times in Biopharmaceuticals
5